How to Buy Nephros Stock

Nephros Inc

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States.

Nephros stock last closed at $3.50, down 7.89% from the previous day, and has increased 116.05% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 1.27 percentage points. Nephros stock is currently +135.69% from its 52-week low of $1.49, and -45.48% from its 52-week high of $6.42.

As of Mar 13, 2026, there are 10.64M shares of NEPH outstanding. The market value of NEPH is $37.25M. In the past 24 hours, 69,000 NEPH shares were traded.

How to Buy Nephros Stock

Not sure how to invest in Nephros stock? Here's how.

  1. Decide where to buy Nephros stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Nephros stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit money your investment account: Choose your method of payment and add your information.
  4. Analyze Nephros stock: The Nephros ticker symbol is NEPH. Is Nephros stock a good investment? Should you buy shares of NEPH? How do NEPH's underlying business fundamentals look? Do top analysts think Nephros is a good buy? Why has NEPH's stock price moved recently? (Hint: Our stock market research tools can help you decide if NEPH is a good stock to buy).
  5. Place your NEPH purchase: Decide if you will purchase NEPH shares at the current market price or use a limit order to purchase NEPH stock at a given price.
  6. Track your NEPH position: Create a watchlist to key updates about your investment in Nephros stock.

Step 1: Decide where to buy Nephros stock

You need an online brokerage account in order to access the NASDAQ market and buy NEPH stock.

A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world financial markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked the best brokerage, the next step is to fill out some personal details so you are able to invest in NEPH today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal details to open your new brokerage account.
  1. Submit your info by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your investment account

Now that you have finished signing up on one of the best stock trading apps, your next step is to transfer the money for your investment:

Check out the video below if you need help transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Nephros stock

Once you have decided on the best place to buy Nephros stock, it's important to research their stock before you invest, so you truly understand the risk and upside.

Nephros Numbers

NEPH Price
$3.50
1w %
-9.56%
1y %
116.05%
5y %
-52.57%
P/E
31.82x
P/B
3.65x
P/S
1.98x
PEG
1x
Revenue
$18.79M
Earnings
$1.19M
Fore. Rev. Growth
12.82%
Fore. Earn. Growth
39.09%
Market Cap
$37.25M
Next Earnings
May 13, 2026
Next Dividend
N/A

NEPH Due Diligence Checks

WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis in less time.

You can see all of the due diligence checks on NEPH's stock page.

Is NEPH stock undervalued or overvalued?

You can use many financial metrics, analyses, models, and charts to gauge NEPH's intrinsic value.

Using relative valuations ratios:

  • NEPH could be undervalued based on its P/E ratio of 31.82x, relative to Medical Instruments & Supplies industry P/E ratio of -410.01x
  • NEPH may be overvalued based on its P/B ratio of 3.65x, relative to Medical Instruments & Supplies industry P/B ratio of 3.4x
  • NEPH may be overvalued based on its PEG ratio of 1x

You can do additional valuation research on NEPH's stock here.

NEPH Financial Overview

Pros:

  • NEPH earnings of $1.21M is not sufficient to cover its interest payments.
  • NEPH has a low debt to equity ratio of 0.34.
  • NEPH profit margin has gone up from 0.5% to 6.4% in the past year.
  • NEPH's operating cash flow of $1.65M allows it to safely service it's debt of $1.06M.
  • There are more short-term assets than long-term liabilities on the NEPH balance sheet.
  • There are more short-term assets than short-term liabilities on the NEPH balance sheet.

Cons:

  • Total NEPH debt is higher than 5 years ago, relative to shareholder equity.

You can dig deeper into what analysts are saying on the Nephros stock forecast page.

NEPH Trading Indicators

SMA10
3.89
SMA20
3.91
SMA50
4.26
SMA100
4.67
SMA200
4.35
MACD
-0.12
MACD Signal
-0.12
MACD Histogram
0
RSI
37.31
Stochastic %K
16.69
Stochastic %D
38.36
StochRSI %K
26.79
StochRSI %D
57.35

How is NEPH performing as a company?

Last year, NEPH earnings were $1.19M. Over the past one years, NEPH's earnings have grown by 1,000% per year. This was faster than the Medical Instruments & Supplies industry average of 10.73%.

Last year, NEPH revenue was $18.79M. In the last five year, NEPH's revenue has gone up by 17.02% per year. This was slower than the Medical Instruments & Supplies industry average of 18.33%.

Dive into NEPH's earnings and revenue performance here.

Are NEPH executives and large shareholders buying or selling the stock?

In the last year, executives and large shareholders at NEPH have not bought or sold any shares.

Dig into more about who owns NEPH shares here.

Can I rely on NEPH as an income stream?

No, Nephros doesn't provide an income stream by paying out dividends.

What do other investors have to say about NEPH?

One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Place your NEPH purchase

You have two primary options:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are mostly the best for newer investors.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at an exact dollar amount, use a limit order.

Click the Open button and your broker will execute your order.

If you need additional help investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Track your NEPH position

Now that you own some NEPH shares, you'll want to keep up with your company.

Start a watchlist to track the latest developments regarding your NEPH stock.

NEPH Feed

How to Buy Stock in Nephros

To reiterate, here are the 6 steps you need to take to buy Nephros stock right now:

  1. Decide where to buy Nephros stock
  2. Create your brokerage account
  3. Deposit money your investment account
  4. Analyze Nephros stock
  5. Place your NEPH purchase
  6. Track your NEPH position

If you require a brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get the latest news on your new investment in Nephros, create a watchlist today.

NASDAQ: NEPH
$3.50-0.30 (-7.89%)
Updated Mar 13, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: NEPH
$3.50-0.30 (-7.89%)
Updated Mar 13, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Nephros share?

As of Mar 13, 2026, it costs $3.50 to buy one share of Nephros stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.286 shares of NEPH.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Nephros stock?

One way to place an order for Nephros stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.